VIM and cancer: A similar mechanism has been postulated for the progression/acquisition of invasive characteristics by cancer cells, which is considered to be a type of EMT; tenascin-C is abundantly detected in the invasive margin of cancers, where the cancer cells express an intermediate filament, vimentin, a marker of EMT in neoplastic cells [34,35].